Anti-Covid medicine successfully produced

Myanmar FDA-recommended Paclovid (oral drug) for Covid-19.

Anti-Covid medicine will be produced when an order is received from the Ministry of Health, according to the Myanma Pharmaceutical Industry, Ministry of Industry.
Myanma Pharmaceutical Industry produces various kinds of medicines, including Covid vaccines, for the Ministry of Health and has been producing K55 billion worth of COVID vaccines since the outbreak of the pandemic.
Paclovid (Nirmatrelvir 150 mg + Ritonavir 100 mg) is a kind of Covid drug.
A packet of Paclovid (30 capsules) costs K250,000 and is available only on prescription, according to Pacific Medical Industries.
Pacific Medical Industries Ltd successfully produced the medicine with Myanmar FDA recommendation number (2308ND 012). The medicine is also recommended by WHO, US FDA, UK MHRA, Korean FDA, and Singapore FDA. — TWA/GNLM

Share this post
Hot News
Hot News
SAC Chairman PM Senior General Min Aung Hlaing lays bejewelled stake for Sarso Beikman construction
Rehabilitation efforts require sufficient time
Eradication of illegal trade must be designated as a national duty for all
Myanmar hosts ASEAN Tourism Committee Meetings
MNHRC Chairman inspects Insein Prison
MoL Union Minister receives IOM Chief
Myanmar seeks African investment at 14th Europe-Africa Forum in Brussels
DEMU carriages operate Yangon-Bago route, serving 700 passengers daily
Kyaiktiyo to begin Buddha Pujaniya Festival on Full Moon of Thadingyut
MFSPEA invites member companies to engage in competitive pricing